Weekly nab-paclitaxel plus carboplatin as neoadjuvant therapy for IIIA-N2 lung squamous cell carcinoma: A prospective phase II study.

被引：1
|
作者：
Zhu, Jian-Quan
Zhang, Yu
Yue, Dongsheng
Zhao, Xiaoliang
Zhang, Qiang
Chen, Hui
Wang, Changli
机构：
[1] Tianjin Canc Hosp, Tianjin, Peoples R China
[2] Tianjin Med Univ, Canc Inst & Hosp, Tianjin, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e20501
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20501
引用
收藏
页数：1
相关论文
共 50 条
  • [31] A randomized phase III study comparing carboplatin with nab-paclitaxel versus docetaxel for elderly patients with squamous-cell lung cancer: Capital study.
    Hamamoto, Yoichiro
    Kogure, Yoshihito
    Kada, Akiko
    Hashimoto, Hiroya
    Atagi, Shinji
    Takiguchi, Yuichi
    Saka, Hideo
    Ebi, Noriyuki
    Inoue, Akira
    Kurata, Takayasu
    Yamanaka, Takeharu
    Ando, Masahiko
    Iwasawa, Shunichiro
    Kubota, Kaoru
    Takenoyama, Mitsuhiro
    Seto, Takashi
    Yamamoto, Nobuyuki
    Gemma, Akihiko
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [32] Metronomic therapy with 5-FU, weekly nab-paclitaxel, leucovorin, and oxaliplatin, plus bevacizumab for advanced pancreatic cancer: A phase II study.
    Isacoff, William H.
    Reber, Howard A.
    Hines, Oscar J.
    Donahue, Timothy R.
    Purcell, Fay M.
    Clerkin, Barbara M.
    Clerkin, Kara M.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [33] Phase II Study of Neoadjuvant Weekly nab-Paclitaxel and Carboplatin, With Bevacizumab and Trastuzumab, As Treatment For Women With Locally Advanced HER2+ Breast Cancer
    Yardley, Denise A.
    Raefsky, Eric
    Castillo, Raul
    Lahiry, Anup
    LoCicero, Richard
    Thompson, Dana
    Shastry, Mythili
    Burris, Howard A., III
    Hainsworth, John D.
    CLINICAL BREAST CANCER, 2011, 11 (05) : 297 - 305
  • [34] A Phase II Trial of Neoadjuvant nab-paclitaxel, Carboplatin, and Gemcitabine (ACaG) in Patients With Locally Advanced Carcinoma of the Bladder
    Grivas, Petros D.
    Hussain, Maha
    Hafez, Khaled
    Daignault-Newton, Stephanie
    Wood, David
    Lee, Cheryl T.
    Weizer, Alon
    Montie, James E.
    Hollenbeck, Brent
    Montgomery, Jeffrey S.
    Alva, Ajjai
    Smith, David C.
    UROLOGY, 2013, 82 (01) : 111 - 117
  • [35] nab-paclitaxel plus carboplatin induction followed by nab-paclitaxel maintenance in squamous non-small cell lung cancer (NSCLC): Results from the ABOUND. sqm study
    Spigel, D. R.
    Jotte, R. M.
    Ponce Aix, S.
    Gressot, L.
    Morgensztern, D.
    McCleod, M.
    Socinski, M. A.
    Daniel, D.
    Juan-Vidal, O.
    Kim, E. S.
    West, H. J.
    Chen, T.
    Bhore, R.
    Ong, T. J.
    Gridelli, C.
    Thomas, M.
    ANNALS OF ONCOLOGY, 2018, 29
  • [36] A randomised phase II clinical trial of nab-paclitaxel and carboplatin compared with gemcitabine and carboplatin as first-line therapy in advanced squamous cell lung carcinoma (C-TONG1002)
    Wang, Zhen
    Huang, Cheng
    Yang, Jin-Ji
    Song, Yong
    Cheng, Ying
    Chen, Gong-Yan
    Yan, Hong-Hong
    Ben, Xiao-Song
    Wang, Bin-Chao
    Xu, Chong-Rui
    Jiang, Ben-Yuan
    Zhou, Qing
    Chen, Hua-Jun
    Wu, Yi-Long
    EUROPEAN JOURNAL OF CANCER, 2019, 109 : 183 - 191
  • [37] Multicenter phase II trial of neoadjuvant carboplatin, weekly nab-paclitaxel, and trastuzumab in stage II-III HER2+breast cancer: A BrUOG study
    Sinclair, Natalie Faye
    Sakr, Bachir Joseph
    Abu-Khalaf, Maysa M.
    Somlo, George
    Black, Robert C.
    Chung, Gina G.
    Rizack, Tina
    Strenger, Rochelle
    Fenton, Mary Anne
    DiGiovanna, Michael
    Constantinou, Maria
    Lannin, Donald R.
    Legare, Robert Duffy
    Chagpar, Anees B.
    Sambandam, Sundaresan T.
    Bossuyt, Veerie
    Rosati, Kayla
    Harris, Lyndsay
    Sikov, William M.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [38] Phase II Study of Modified Carboplatin Plus Weekly Nab-Paclitaxel in Elderly Patients with Non-Small Cell Lung Cancer: North Japan Lung Cancer Study Group Trial 1301
    Miyauchi, Eisaku
    Inoue, Akira
    Usui, Kazuhiro
    Sugawara, Shunichi
    Maemondo, Makoto
    Saito, Heisuke
    Fujita, Yuka
    Kato, Terufumi
    Suzuki, Toshiro
    Harada, Toshiyuki
    Watanabe, Hiroshi
    Nakagawa, Taku
    Ichinose, Masakazu
    ONCOLOGIST, 2017, 22 (06): : 640 - +
  • [39] A prospective phase II study of induction erlotinib therapy in stage IIIA-N2 non-small cell lung cancer
    Zhong, Wenzhao
    Yang, Xuening
    Liao, Riqiang
    Nie, Qiang
    Su, Jian
    Chen, Zhihong
    Zhang, Xuchao
    An, Shejuan
    Zhou, Qing
    Yang, Jinji
    Wu, Yi Long
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [40] A PROSPECTIVE PHASE II STUDY OF INDUCTION ERLOTINIB THERAPY IN STAGE IIIA-N2 NON-SMALL-CELL LUNG CANCER
    Zhong, W. -Z.
    Yang, X. -N.
    Liao, R. -Q.
    Nie, Q.
    Su, J.
    Zhang, X. -C.
    An, S. -J.
    Zhou, Q.
    Yang, J. -J.
    Wu, Y. -L.
    ANNALS OF ONCOLOGY, 2012, 23 : 43 - 43
12345